{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:26Z","timestamp":1786119326447,"version":"build-2736575974"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/hco.0b013e3283336d52","type":"journal-article","created":{"date-parts":[[2009,12,5]],"date-time":"2009-12-05T03:20:46Z","timestamp":1259983246000},"page":"1-7","source":"Crossref","is-referenced-by-count":37,"title":["Persistent atrial fibrillation: current approach and controversies"],"prefix":"10.1097","volume":"25","author":[{"given":"Ratika","family":"Parkash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony SL","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210204","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.hrthm.2007.04.005","article-title":"HRS\/EHRA\/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation","volume":"4","author":"Calkins","year":"2007","journal-title":"Heart Rhythm"},{"issue":"Suppl B","key":"R2-2-20210204","first-page":"9B","article-title":"Introduction: 2004 Canadian Cardiovascular Society Consensus Conference - Atrial Fibrillation.","volume":"21","author":"Kerr","year":"2005","journal-title":"Can J Cardiol"},{"key":"R3-2-20210204","first-page":"869","article-title":"Population rates of hospitalization for atrial fibrillation\/flutter in Canada","volume":"20","author":"Humphries","year":"2004","journal-title":"Can J Cardiol"},{"key":"R4-2-20210204","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"R5-2-20210204","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1524-4733.2006.00124.x","article-title":"Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States","volume":"9","author":"Coyne","year":"2006","journal-title":"Value Health"},{"key":"R6-2-20210204","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(06)68037-9","article-title":"Controversies in atrial fibrillation","volume":"367","author":"Nattel","year":"2006","journal-title":"Lancet"},{"key":"R7-2-20210204","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"R8-2-20210204","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"R9-2-20210204","doi-asserted-by":"crossref","first-page":"H2898","DOI":"10.1152\/ajpheart.00546.2006","article-title":"Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes","volume":"292","author":"Saygili","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R10-2-20210204","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"R11-2-20210204","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"key":"R12-2-20210204","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00395-005-0571-2","article-title":"ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation","volume":"101","author":"Boldt","year":"2006","journal-title":"Basic Res Cardiol"},{"key":"R13-2-20210204","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.2003.015347","article-title":"Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease","volume":"90","author":"Boldt","year":"2004","journal-title":"Heart"},{"key":"R14-2-20210204","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"Burstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R15-2-20210204","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehi350","article-title":"Inflammation in the genesis and perpetuation of atrial fibrillation","volume":"26","author":"Engelmann","year":"2005","journal-title":"Eur Heart J"},{"key":"R16-2-20210204","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jacc.2005.06.053","article-title":"High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion","volume":"46","author":"Malouf","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R17-2-20210204","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2003.11.062","article-title":"Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation","volume":"43","author":"Conway","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R18-2-20210204","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.amjcard.2004.11.032","article-title":"Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation","volume":"95","author":"Psychari","year":"2005","journal-title":"Am J Cardiol"},{"key":"R19-2-20210204","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2004.09.045","article-title":"Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation","volume":"45","author":"Ellinor","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R20-2-20210204","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/europace\/eul060","article-title":"Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.","volume":"8","author":"Rienstra","year":"2006","journal-title":"Europace"},{"key":"R21-2-20210204","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.amjcard.2005.12.071","article-title":"Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation","volume":"97","author":"Yamada","year":"2006","journal-title":"Am J Cardiol"},{"key":"R22-2-20210204","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/eurheartj\/ehi648","article-title":"Reduced apelin levels in lone atrial fibrillation","volume":"27","author":"Ellinor","year":"2006","journal-title":"Eur Heart J"},{"key":"R23-2-20210204","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa0805710","article-title":"Valsartan for prevention of recurrent atrial fibrillation","volume":"360","author":"Disertori","year":"2009","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R24-2-20210204","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.jelectrocard.2006.05.021","article-title":"The neural basis of atrial fibrillation.","volume":"39","author":"Scherlag","year":"2006","journal-title":"J Electrocardiol"},{"key":"R25-2-20210204","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1540-8167.2007.00976.x","article-title":"Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE)","volume":"18","author":"Lin","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8A","key":"R26-2-20210204","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"R27-2-20210204","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1161\/01.CIR.96.7.2455","article-title":"Incidence of and risk factors for atrial fibrillation in older adults","volume":"96","author":"Psaty","year":"1997","journal-title":"Circulation"},{"key":"R28-2-20210204","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.HYP.25.3.305","article-title":"Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988\u20131991","volume":"25","author":"Burt","year":"1995","journal-title":"Hypertension"},{"issue":"10A","key":"R29-2-20210204","doi-asserted-by":"crossref","first-page":"9G","DOI":"10.1016\/S0002-9149(03)00227-3","article-title":"Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target","volume":"91","author":"Healey","year":"2003","journal-title":"Am J Cardiol"},{"key":"R30-2-20210204","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIRCULATIONAHA.108.830042","article-title":"Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women","volume":"119","author":"Conen","year":"2009","journal-title":"Circulation"},{"key":"R31-2-20210204","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jama.297.7.709","article-title":"Pulse pressure and risk of new-onset atrial fibrillation","volume":"297","author":"Mitchell","year":"2007","journal-title":"JAMA"},{"key":"R32-2-20210204","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"R33-2-20210204","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.bjp.0706445","article-title":"Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins","volume":"147","author":"Chen","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R34-2-20210204","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/eurheartj\/ehl360","article-title":"Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation","volume":"27","author":"Kistler","year":"2006","journal-title":"Eur Heart J"},{"key":"R35-2-20210204","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehi668","article-title":"Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence","volume":"27","author":"Ehrlich","year":"2006","journal-title":"Eur Heart J"},{"key":"R36-2-20210204","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/01.HYP.0000257123.95372.ab","article-title":"Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts","volume":"49","author":"Choisy","year":"2007","journal-title":"Hypertension"},{"key":"R37-2-20210204","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ahj.2007.06.045","article-title":"Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias","volume":"154","author":"Saksena","year":"2007","journal-title":"Am Heart J"},{"key":"R38-2-20210204","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"R39-2-20210204","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF) \u2013 a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"R40-2-20210204","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study","volume":"41","author":"Carlsson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R41-2-20210204","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.126.2.476","article-title":"Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study","volume":"126","author":"Opolski","year":"2004","journal-title":"Chest"},{"key":"R42-2-20210204","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.","volume":"347","author":"van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"R43-2-20210204","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.165.3.258","article-title":"Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis","volume":"165","author":"de Denus","year":"2005","journal-title":"Arch Intern Med"},{"key":"R44-2-20210204","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"R45-2-20210204","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N Engl J Med"},{"key":"R46-2-20210204","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"issue":"9 Suppl","key":"R47-2-20210204","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1046\/j.1540-8167.14.s9.17.x","article-title":"Rhythm versus rate control trials in atrial fibrillation","volume":"14","author":"Wyse","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R48-2-20210204","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N Engl J Med"},{"key":"R49-2-20210204","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.jacc.2003.12.054","article-title":"A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate","volume":"43","author":"Nademanee","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R50-2-20210204","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1540-8167.2008.01285.x","article-title":"A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation","volume":"20","author":"Nair","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R51-2-20210204","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archinte.168.6.581","article-title":"Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review","volume":"168","author":"Noheria","year":"2008","journal-title":"Arch Intern Med"},{"key":"R52-2-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ahj.2009.05.012","article-title":"Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials","volume":"158","author":"Dagres","year":"2009","journal-title":"Am Heart J"},{"key":"R53-2-20210204","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jacc.2009.02.022","article-title":"Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation","volume":"53","author":"Cappato","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R54-2-20210204","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2008.10.054","article-title":"A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation","volume":"53","author":"Oral","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R55-2-20210204","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1540-8167.2005.00308.x","article-title":"Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias","volume":"16","author":"Haissaguerre","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R56-2-20210204","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/eurheartj\/ehn302","article-title":"Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation","volume":"29","author":"Knecht","year":"2008","journal-title":"Eur Heart J"},{"key":"R57-2-20210204","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/eurheartj\/ehp063","article-title":"Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint","volume":"30","author":"O'Neill","year":"2009","journal-title":"Eur Heart J"},{"key":"R59-2-20210204","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.108.825380","article-title":"Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop","volume":"119","author":"Benjamin","year":"2009","journal-title":"Circulation"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HCO.0b013e3283336d52","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:02:01Z","timestamp":1786039321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001573-201001000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e3283336d52","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}